Latest News

NEW YORK — Incorporating whole-genome sequencing into healthcare around Stockholm has enabled more than 1,000 people with a rare disease to receive a molecular diagnosis, a new study has found. The Karolinska University Hospital and the Science for Life Laboratory (SciLifeLab) launched the Genomic Medicine Center Karolinska-Rare Disease (GMCK-RD), an...
A streamlined whole-genome sequencing approach can provide rapid and accurate genomic profiling for acute myeloid leukemia (AML) or myelodysplastic syndromes, according to a study published in the March 11 issue of the New England Journal of Medicine. Eric J. Duncavage, M.D., from the Washington University School of Medicine in St....
Arlington, Texas – A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders. The study, published in the peer-reviewed journal Cell Reports, sheds light on why immunotherapy treatments don’t work for all...
Doha, Qatar – In the heart of Doha’s Education City, a vast, sun-bleached campus of tech companies and universities, lies a healthcare facility that Qatar hopes will become a beacon of personalised medicine within the Middle East. Defined by the giant glass and ceramic wings which adorn the outside of...
ORLANDO – The majority of men who receive one of the standard treatments for localized prostate cancer – surgery or radiation therapy – have an excellent outcome. But for the small group whose prostate cancer returns, a new study offers insight as to why treatment isn’t effective. The study –...
AUGUSTA, Ga. — The Nintendo Wii may help treat symptoms of Parkinson’s disease, including depression, a Medical College of Georgia researcher says. Parkinson’s disease is a degenerative disease that impairs motor skills. Dr. Herz theorized that the popular computer game console, which simulates various sports and activities, could improve coordination,...
PHILADELPHIA, PA — The Wistar Institute’s David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center (VIC) and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research, and collaborators, have engineered novel monoclonal antibodies that engage Natural Killer cells through a unique surface receptor that activates...